CLINICAL STUDY REPORTING

PHASTAR has a unique approach to the analysis and reporting of clinical trials. All our staff are trained in "The PHASTAR Discipline" - our in-house philosophy relating to the methodology of clinical trial data analysis and reporting.

PHASTAR has experience in all therapeutic areas, including:

  • Oncology
  • Rheumatoid Arthritis
  • Asthma, COPD and Respiratory Diseases
  • Vaccines
  • Pain, Headache, Migraine
  • Metabolic Disorders (e.g. Diabetes, Lipids)
  • Haematology
  • Cardiovascular
  • Gastro-Intestinal
  • Anti-Infectives
  • Dermatology
  • Neurological Disorders (e.g. Depression, Epilepsy, MS)

Read our case study

We cover all phases including the following types of studies:

  • Adaptive designs
  • Crossover and parallel group
  • Drug interaction
  • Absolute and relative bioequivalence
  • Radiotracer
  • Superiority, equivalence and non-inferiority
  • SAD/MAD
  • Food effect
  • Meta-analyses and Integrated datasets
  • Observational
  • Single dose and steady state
  • Special populations e.g. renal and liver impairment studies

Our services include:

  • Reporting of phase I-IV trials
  • Integrated summaries of efficacy and safety
  • Conversion of legacy data to CDISC standards
  • Creation of SDTM and ADaM datasets
  • CDISC compliant documentation
  • Annotated CRFs
  • Define.xml and/or define.pdf
  • Meta-analyses
  • Meta-analyses and Integrated datasets
  • Observational and real-world evidence studies
  • Superiority, equivalence and non-inferiority
  • Clinical pharmacology studies (e.g. drug interaction, bioequivalence, radiotracer, food effect, special populations, renal and liver impairment studies)

CDISC

PHASTAR's Programming team provide expert CDISC services as well as the development of dataset specifications. If you have a submission approaching with legacy format datasets, PHASTAR can upgrade these to CDISC compliant datasets (SDTM and ADaM). PHASTAR’s senior team has extensive experience with regulatory bodies and participate in regular regulatory interactions.

We can provide all the necessary associated documentation that a submission to the FDA will require (or other global regulators), including annotated CRFs, define.xml and/or define.pdf and a regulatory reviewer's guide. If you are planning an integrated summary of efficacy and safety, we can help put together CDISC compliant datasets. We can also provide advice on the format of the data that will be acceptable to global regulatory bodies.

What our clients say

Interested? Click on the button to see our Case Studies

NEED HELP WITH A PROJECT?

WE ARE HELP YOU TO GROW YOUR BUSINESS

Business Consulting

Nam eget justo risus. Morbi elit nulla, eleifend vitae justo et, laoreet tincidunt metus nec urna scelerisque

Insurance Consulting

Nam eget justo risus. Morbi elit nulla, eleifend vitae justo et, laoreet tincidunt metus nec urna scelerisque

Financial Consulting

Fusce at accumsan justo. Nulla lacus efficitur vel aliquam sed iaculis ac sem sed, ullamcorper aliquet lorem

Retirement Strategies

Nam eget justo risus. Morbi elit nulla, eleifend vitae justo et, laoreet tincidunt metus nec urna scelerisque

Taxes Planning

Nam eget justo risus. Morbi elit nulla, eleifend vitae justo et, laoreet tincidunt metus nec urna scelerisque

Business Loan

Nam eget justo risus. Morbi elit nulla, eleifend vitae justo et, laoreet tincidunt metus nec urna scelerisque